ASCP MB Exam Questions and Answers
100% Pass
Acute Promylocity Leukemia (APL) ✔✔t(15:17)
PML / RARa genes
Chronic Myelogenous Leukemia (CML) ✔✔t(9:22)
a.k.a. Philadelphia chromosome
ABL1 / BCR genes
Burkitt's non-
...
ASCP MB Exam Questions and Answers
100% Pass
Acute Promylocity Leukemia (APL) ✔✔t(15:17)
PML / RARa genes
Chronic Myelogenous Leukemia (CML) ✔✔t(9:22)
a.k.a. Philadelphia chromosome
ABL1 / BCR genes
Burkitt's non-Hodkin's Lymphoma ✔✔t(8:14)
dysregulation of c-myc gene
breakpoints on ch.8 spread over 190kbp region 5' to 3'
Follicular non-Hodkin's Lymphoma ✔✔t(14:18)
IgH / BCL2 genes
Mantle Cell Lymphoma (MCL) ✔✔t(11:14)
CCND1 / IgH genes
overexpression of cyclin D1 (cell cycle gene)
MALT Lymphoma
(a.k.a. Marginal Zone) ✔✔t(11:18)
API2 / MLT genes
"mucosa-associated lymphoid tissue"
Haploid Genome ✔✔3.3 billion bp
Carbamazepine Resistance ✔✔HLA B1502
Factor V Leiden ✔✔c.1691G>A / p.R506Q
causes Thrombophilia
Cystic Fibrosis mutation ✔✔delta F508, 3bp deletion
HERceptin Therapy ✔✔HER2+/neu
Overexpression of HER2 receptors causing cancer cells to grow
Vancomycin Resistance (Enterococcus) ✔✔van A
MRSA (resistant staph) ✔✔mec A
Mycobacterium tuberculosis ✔✔katG, inhA
Most cancerous HPV ✔✔Strain 16 - 70% of all cases
Graft vs Host Disease ✔✔Linked w CMV replication
(Cytomegalovirus)
Viral load change HCV ✔✔.3log10
Viral load change HIV ✔✔.5log10
HCV Genotypes ✔✔Genotype 1 - 75%
Genotype 2 and 3 - 20-25%
DNA A260 ✔✔50ug/ml/1OD
(answer on ascp is .560)
What inhibits topoisomerase? ✔✔Irinotecan
KCL in PCR ✔✔Helps short DNA fragments
range 100bp to 1000bp at 70mM to 100mM
FISH ✔✔Prade-Willi
# of amplification products ✔✔(1+E)^n
RNA POL I ✔✔rRNA
RNA POL II ✔✔mRNA, snRNA
RNA POL III ✔✔tRNA
RNA POL IV ✔✔mitochondrial RNA
Histones ✔✔Ionic;
(+) charged Arginine and Lysine
Cutaneous T-Cell Lymphoma
(CTCL) ✔✔Vorinostat - 1st FDA approved drug
(also treats Sezary syndrome)
HCV most virulent ✔✔1b
HCV most conserved ✔✔5' UTR
HLA want to PCR HLA-D ✔✔beta exon 2
Invader Assay enzyme ✔✔Cleavase
Melting temp question ✔✔48
Why primer dimers ✔✔3' complementarity
A260/A280 ✔✔Protein < 1.8-2.0 < RNA
Telomerase ✔✔Reverse transcriptase
Fragile X Syndrome ✔✔>200 CGG repeats
5'UTR of chr.X
Huntington's Disease ✔✔>40 CAG repeats
ex1 chr.4
Common oncogene ✔✔K-Ras
Protein involved in cell division
Common tumor suppressor ✔✔TP53
Leading DNA Pol ✔✔Delta
Lagging DNA Pol ✔✔Alpha
Repair DNA Pol ✔✔Epsilon
Mitochondrial DNA Pol ✔✔Gamma
Taq polymerase ✔✔5'-3' exonuclease
bDNA enzyme ✔✔alakaline phosphatase
Separates DNA ✔✔helicase
Unwinds DNA ✔✔topoisomerase
Nephrotic kidney
(Post-transplant virus) ✔✔BK virus
Kidney Failure ✔✔HIV
EBV - Epstein-Barr virus
aka "Herpes" ✔✔Post-transplant Lymphoproliferative patients
Early diagnosis of EBV ✔✔RT-qPCR
homologous chismata formation ✔✔prophase I
Cell cycle entry ✔✔G1 to S
Hallmark feature of TNR disorders ✔✔Anticipation
[HLA Typing]
Advantage of molecular testing over seriological phenotyping? ✔✔1. Viable cells are NOT needed
2. Null alleles can be detected
[Show More]